Transient Fluorescent Tattoos Mark Surgical Sites
|
By HospiMedica International staff writers Posted on 05 Jan 2017 |

Image: A new temporary pigment marks dermal surgical sites (Photo courtesy Hsian-Rong Tseng/ CNSI).
A new study describes a novel ink to mark surgery targets on the skin, which glows only under certain light conditions and disappears altogether after a period of time.
Developed by researchers at the California NanoSystems Institute (CNSI; Santa Barbara, CA, USA), Academia Sinica (Taipei, Taiwan), and other institutions, the time-limited pigment is based on cross-linked fluorescent supramolecular nanoparticles (c-FSNPs), which encapsulate a fluorescent conjugated polymer into a core via a supramolecular synthetic approach. The result is micrometer-sized c-FSNPs, which exhibit an ideal size-dependent intradermal retention time of up to three months.
The temporary pigment has optimized photophysical properties and intradermal retention time for successful in vivo finite tattooing. Under ambient lighting, the nanoparticles are invisible, avoiding unwanted markings on a patient's skin; but under a light at a wavelength of 465 nanometers, the pigment glows fluorescently, marking the surgical target. In addition, the inflammatory responses induced by c-FSNPs are undetectable after tattooing. The study describing the new pigment was published on November 30, 2016, in ACS Nano.
“Commercially available tattoo pigments possess several issues, which include causing poor cosmesis, being mistaken for a melanocytic lesion, requiring additional removal procedures when no longer desired, and potentially inducing inflammatory responses,” concluded senior author Hsian-Rong Tseng, PhD, of CNSI, and colleagues. “We believe that the c-FSNPs can serve as a ‘finite tattoo’ pigment to label potential malignant nonmelanoma skin cancer lesions.”
Tattooing has been utilized by the medical community for precisely demarcating anatomic landmarks, which is especially important for identifying biopsy sites of nonmelanoma skin cancer (NMSC) due to the long interval between the initial diagnostic biopsy and surgical treatment.
Related Links:
California NanoSystems Institute
Academia Sinica
Developed by researchers at the California NanoSystems Institute (CNSI; Santa Barbara, CA, USA), Academia Sinica (Taipei, Taiwan), and other institutions, the time-limited pigment is based on cross-linked fluorescent supramolecular nanoparticles (c-FSNPs), which encapsulate a fluorescent conjugated polymer into a core via a supramolecular synthetic approach. The result is micrometer-sized c-FSNPs, which exhibit an ideal size-dependent intradermal retention time of up to three months.
The temporary pigment has optimized photophysical properties and intradermal retention time for successful in vivo finite tattooing. Under ambient lighting, the nanoparticles are invisible, avoiding unwanted markings on a patient's skin; but under a light at a wavelength of 465 nanometers, the pigment glows fluorescently, marking the surgical target. In addition, the inflammatory responses induced by c-FSNPs are undetectable after tattooing. The study describing the new pigment was published on November 30, 2016, in ACS Nano.
“Commercially available tattoo pigments possess several issues, which include causing poor cosmesis, being mistaken for a melanocytic lesion, requiring additional removal procedures when no longer desired, and potentially inducing inflammatory responses,” concluded senior author Hsian-Rong Tseng, PhD, of CNSI, and colleagues. “We believe that the c-FSNPs can serve as a ‘finite tattoo’ pigment to label potential malignant nonmelanoma skin cancer lesions.”
Tattooing has been utilized by the medical community for precisely demarcating anatomic landmarks, which is especially important for identifying biopsy sites of nonmelanoma skin cancer (NMSC) due to the long interval between the initial diagnostic biopsy and surgical treatment.
Related Links:
California NanoSystems Institute
Academia Sinica
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







